Literature DB >> 13879842

Use of dimercaprol or pencillamine in the treatment of cystinosis.

B E CLAYTON, A D PATRICK.   

Abstract

Entities:  

Keywords:  CYSTINOSIS/therapy; DIMERCAPROL/therapy; VALINE/related compounds

Mesh：

Substances：

Year:  1961        PMID： 13879842

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Cystine depletion of cystinotic cells by aminothiols.

Authors:  J G Thoene; R G Oshima; J C Crawhall; J A Schneider
Journal:  Proc R Soc Med       Date:  1977

2.  LEAD POISONING IN CHILDREN.

Authors:  A A MONCRIEFF; O P KOUMIDES; B E CLAYTON; A D PATRICK; A G RENWICK; G E ROBERTS
Journal:  Arch Dis Child       Date:  1964-02       Impact factor: 3.791

3.  DISORDERS OF AMINO-ACID TRANSPORT.

Authors:  M D MILNE
Journal:  Br Med J       Date:  1964-02-08

4.  FURTHER OBSERVATIONS ON USE OF D-PENICILLAMINE IN CYSTINURIA.

Authors:  J C CRAWHALL; E F SCOWEN; R W WATTS
Journal:  Br Med J       Date:  1964-05-30

5.  [THE POSSIBILITY OF A DIETARY INFLUENCE ON CYSTINOSIS].

Authors:  F LINNEWEH
Journal:  Klin Wochenschr       Date:  1964-07-15

6.  The degradative metabolism of L-cysteine and L-cystine in vitro by liver in cystinosis.

Authors:  A D PATRICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

Review 7.  Cystinosis: a review of the different forms and of recent advances.

Authors:  W Kroll; K H Lichte
Journal:  Humangenetik       Date:  1973

8.  The prognosis and management of renal tubular disorders.

Authors:  M D Milne
Journal:  Proc R Soc Med       Date:  1967-11-01

9.  Treatment of homocystinuria.

Authors:  H P Chase; S I Goodman; D O'Brien
Journal:  Arch Dis Child       Date:  1967-10       Impact factor: 3.791

Review 10.  Recent advances in the treatment of cystinosis.

Authors:  J A Schneider; K F Clark; A A Greene; J S Reisch; T C Markello; W A Gahl; J G Thoene; P K Noonan; K A Berry
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.